作者: Richard D. Burt , Hanne Thiede , Holly Hagan
DOI: 10.1016/J.DRUGALCDEP.2009.07.005
关键词:
摘要: Abstract Background Hepatitis C virus (HCV) is a major health problem among injection drug users (IDU). One potential means of reducing risk HCV transmission IDU serosorting, whereby preferentially share equipment with persons like status. Methods We surveyed Seattle area recruited by respondent-driven sampling as part the National HIV/AIDS Behavioral Surveillance system in 2005. Results Of 337 participants, 91% reported ever having been tested for HCV. Fifty-three percent participants who shared any last 12 months knowing status person whom they equipment. Thirty-seven self-reported HCV-positive that their sharing partner was also and 7% HCV-negative partner. Among 11% 23% negative The disproportionate tendency to persisted after control characteristics associated positivity stratified logistic regression analyses. equipment, 39% had intentionally based on knowledge concordant Conclusions conclude measurable degree serosorting occurring IDU. Promotion may be useful harm reduction strategy continue practice If judged efficacious, would provide further rationale encourage support testing